Meningococcal Disease in US Military Personnel before and After Adoption of Conjugate Vaccine

Meningococcal Disease in US Military Personnel before and After Adoption of Conjugate Vaccine

Bibliographic Details
Main Authors:	Michael P. Broderick, Christopher Phillips, Dennis Faix
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2015-02-01
Series:	Emerging Infectious Diseases
Subjects:	US military meningococcal disease vaccine bacteria
Online Access:	https://wwwnc.cdc.gov/eid/article/21/2/14-1037_article

Similar Items

Meningococcal Disease in US Military Personnel before and after Adoption of Conjugate Vaccine
by: Michael D. Decker
Published: (2016-11-01)

Trends in Meningococcal Disease in the United States Military, 1971–2010
by: Michael P. Broderick, et al.
Published: (2012-09-01)

Meningococcal vaccine evolution
by: Gianni Bona, et al.
Published: (2012-06-01)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
by: Rivero-Calle I, et al.
Published: (2019-10-01)

Vaccines against Meningococcal Diseases
by: Mariagrazia Pizza, et al.
Published: (2020-10-01)

Meningococcal Disease in China
by: Zhujun Shao, et al.
Published: (2016-04-01)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
by: Kadidja Gamougam, et al.
Published: (2015-01-01)

Herd Protection against Meningococcal Disease through Vaccination
by: Stephen A. Clark, et al.
Published: (2020-10-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
by: Miguel Tregnaghi, et al.
Published: (2014-09-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Antibody persistence following meningococcal C conjugate vaccination in children and adolescents infected with human immunodeficiency virus
by: Ana Cristina Cisne Frota, et al.
Published: (2017-09-01)

Variation of meningococcal porin antigens
by: Suker, Janet
Published: (1997)

Invasive Meningococcal Disease in the Vaccine Era
by: Simon Nadel, et al.
Published: (2018-11-01)

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review
by: Jessica Presa, et al.
Published: (2019-07-01)

Mass Vaccination Campaign Following Community Outbreak of Meningococcal Disease
by: Gérard Krause, et al.
Published: (2002-12-01)

Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany
by: Johannes Elias, et al.
Published: (2010-03-01)

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
by: Hoan Jong Lee, et al.
Published: (2014-11-01)

Vacinas meningocócicas conjugadas: eficácia e novas combinações Meningococcal conjugate vaccines: efficacy and new combinations
by: Marco Aurélio Palazzi Sáfadi, et al.
Published: (2006-07-01)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020-04-01)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
by: Helen Campbell, et al.
Published: (2017-07-01)

A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa
by: Muhamed-Kheir Taha, et al.
Published: (2021-03-01)

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
by: Heidi M. Soeters, et al.
Published: (2017-05-01)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES
by: Marco AP Safadi, et al.
Published: (2012-02-01)

Recommendations for the use of meningococcal vaccines in South Africa
by: Susan Meiring, et al.
Published: (2017-10-01)

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
by: Marco Aurelio Palazzi Sáfadi, et al.
Published: (2014-05-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

Health workers’ perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso
by: Sylvain F. Nkwenkeu, et al.
Published: (2020-02-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)

Meningococcal vaccines: past, present, and future perspectives
by: Seyed Davar Siadat and Dariush Norouzian
Published: (2007-10-01)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020-07-01)

Passive smoking, invasive meningococcal disease and preventive measures: a commentary
by: Rashid Harunor, et al.
Published: (2012-12-01)

Surveillance for Invasive Meningococcal Disease in Children, US–Mexico Border, 2005–2008
by: Enrique Chacon-Cruz, et al.
Published: (2011-03-01)

Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence
by: Sara Boccalini, et al.
Published: (2020-10-01)

Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
by: Pei-Lan Shao, et al.
Published: (2009-07-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

Cannot write session to /tmp/vufind_sessions/sess_4ock3pmrelqi18530glh4gt1o6